Detection of particles within the nasal airways before and after nasal decongestion

Clinical Otolaryngology and Allied Sciences

Volumn 26, Issue 4, 2001, Pages 324-328

  Keck, T ^a,b   Leiacker, R ^a   Kuhnemann S ^a   Rettinger, G ^a   Lindemann, J ^a  

^a UNIVERSITY OF ULM   (Germany)

^b NONE   (Germany)

Author keywords

Aerosol; Intranasal measurement; Nasal decongestion; Particle deposition

Indexed keywords

DECONGESTIVE AGENT; STARCH; XYLOMETAZOLINE;

ADULT; AEROSOL; AIRWAY; ARTICLE; BREATHING; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEBULIZER; NORMAL HUMAN; NOSE CAVITY; NOSE MUCOSA; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; RHINOMANOMETRY; SUCTION;

ADULT; AIR POLLUTANTS; FEMALE; HUMANS; IMIDAZOLES; MALE; NASAL DECONGESTANTS; NASAL MUCOSA; RESPIRATION;

EID: 0034799997     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.2001.00483.x     Document Type: Article

References (22)

1. Deposition and clearance of inhaled particles
2. Mechanisms of aerosol deposition in a nasal model
3. The biophysics of nasal airflow
4. Analysis of airflow patterns in the human nose
5. Pharmacological background to decongesting and antiinflammatory treatment of rhinitis and sinusitis
6. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis
7. Experimental studies on the effect of various mucosa decongesting nose drops
8. Vascular effects of topical oxymetazoline on human nasal mucosa
9. Sympathetic vascular control of the pig nasal mucosa: Adrenoreceptor mechanisms in blood flow and volume control
10. Theoretical study of nasal deposition
11. Statistical analysis of aerosol deposition in nose and mouth
12. PartIcle deposition and resistance in the noses of adults and children
13. An experimental method for measuring aerosol deposition efficiency in the human oral airway
14. Increased fine particle deposition in women with asymptomatic nonspecific airway hyperresponsiveness
15. Deposition and disposition of [11C]zanamivir following administration as an intranasal spray. Evaluation with positron emission tomography
16. Experimental deposition of environmental tobacco smoke submicrometer particulate matter in the human respiratory tract
17. Estimating the particle size characteristics of therapeutic aerosols
18. Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump
19. The relationship between particle deposition in the anterior nasal passage and nasal passage characteristics
20. Detection of particles within the nasal airways during respiration
21. Analytische statistik
22. Nasal cavity